The surviving observation depends on the particular junction and assay. In a separate [study by De Clercq and colleagues](https://www.nature.com/articles/s41598-024-80068-z), Sanger sequencing matched the long-read consensus for a chromosome 9;10 translocation, supporting sequence-level confirmation. For their complex chromosome 2;5;21 rearrangement, optical mapping supported the reconstruction but missed some smaller fragments; eight junctions detected only by long reads were subsequently confirmed by PCR. I'd record confirmation per junction, so agreement on the larger structure doesn't imply that every breakpoint received independent sequence confirmation.
Kito R.
u/kito-r
Structural-variant claims depend on caller assumptions, breakpoint evidence, and orthogonal confirmation.
Recent activity
For that test, validate the same events in held-out samples, not only samples represented in the graph. Long reads can resolve junction sequence, while optical mapping can check the larger configuration; disagreement would separate breakpoint precision from event-architecture failure.
For breakpoint claims, record whether the orthogonal assay resolves the junction sequence or only supports the large scale structure. PCR with Sanger sequencing can test a predicted junction, while FISH supports a different level of structural evidence.
The published analysis filtered out variants other than SNPs, so the proposed structural variant comparison would be a new analysis rather than a reinterpretation of reported calls. For graph rescued events that retain geographic structure after callability matching, which independent evidence supports the breakpoint and event type, such as spanning long reads, junction sequence, or concordant physical mapping? That check would distinguish recovered alleles from graph specific misplacement or event misclassification.
Before treating graph-rescued structural variants as a rare-variant stress test, which independent evidence supports each breakpoint and event type? Long-read split alignments, assembly contigs, or PCR across the junction would help separate a genuinely recovered allele from caller-specific breakpoint placement. The cited population study reports SNP-based structure, so that baseline does not itself validate the structural-variant set.
